144 related articles for article (PubMed ID: 10025877)
1. Ki-ras codon 12 point mutational activation in Hong Kong colorectal carcinoma patients.
Ko JM; Cheung MH; Wong CM; Lau KW; Tang CM; Kwan MW; Lung ML
Cancer Lett; 1998 Dec; 134(2):169-76. PubMed ID: 10025877
[TBL] [Abstract][Full Text] [Related]
2. Incidence of ras oncogene activation in lung carcinomas in Hong Kong.
Lung ML; Wong M; Lam WK; Lau KS; Kwan S; Fu KH; Cheung H; Yew WW
Cancer; 1992 Aug; 70(4):760-3. PubMed ID: 1322782
[TBL] [Abstract][Full Text] [Related]
3. Analysis of K-ras codon 12 mutations and p53 overexpression in colorectal nodule-aggregating tumors.
Kusaka T; Fukui H; Sano Y; Ueda Y; Chiba T; Fujimori T
J Gastroenterol Hepatol; 2000 Oct; 15(10):1151-7. PubMed ID: 11106095
[TBL] [Abstract][Full Text] [Related]
4. Differential activation of the c-Ki-ras-2 proto-oncogene in human colorectal carcinoma.
Halatsch ME; Hirsch-Ernst KI; Weinel RJ; Kahl GF
Anticancer Res; 1998; 18(4A):2323-5. PubMed ID: 9703874
[TBL] [Abstract][Full Text] [Related]
5. Transitions and transversions in Ki-ras gene in colorectal cancers in Mexican patients.
Segura-Uribe J; Santiago-Payán H; Quintero A
Tumori; 2003; 89(3):259-62. PubMed ID: 12908779
[TBL] [Abstract][Full Text] [Related]
6. The balanced induction of K-ras codon 12 and 13 mutations in mucosa differs from their ratio in neoplastic tissues.
Kraus MC; Seelig MH; Linnemann U; Berger MR
Int J Oncol; 2006 Oct; 29(4):957-64. PubMed ID: 16964391
[TBL] [Abstract][Full Text] [Related]
7. Ki-ras mutations and prognosis in colorectal cancer.
Kressner U; Bjørheim J; Westring S; Wahlberg SS; Påhlman L; Glimelius B; Lindmark G; Lindblom A; Børresen-Dale AL
Eur J Cancer; 1998 Mar; 34(4):518-21. PubMed ID: 9713302
[TBL] [Abstract][Full Text] [Related]
8. Ki-ras codon 12 point mutation and p53 mutation in pancreatic diseases.
Yamaguchi K; Chijiiwa K; Noshiro H; Torata N; Kinoshita M; Tanaka M
Hepatogastroenterology; 1999; 46(28):2575-81. PubMed ID: 10522044
[TBL] [Abstract][Full Text] [Related]
9. Ras oncogene and p53 gene hotspot mutations in colorectal cancers.
Lin SY; Chen PH; Yang MJ; Chen TC; Chang CP; Chang JG
J Gastroenterol Hepatol; 1995; 10(2):119-24. PubMed ID: 7787154
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the p53 and Ki-ras genes, microsatellite instability and site of tumor origin in colorectal cancer.
Catalano T; Curia MC; Aceto G; Verginelli F; Cascinu S; Cama A; Mariani-Costantini R; Teti D; Battista P
Oncol Rep; 2005 Sep; 14(3):625-31. PubMed ID: 16077965
[TBL] [Abstract][Full Text] [Related]
11. Associations of Ki-ras proto-oncogene mutation and p53 gene overexpression in sporadic colorectal adenomas with demographic and clinicopathologic characteristics.
Einspahr JG; Martinez ME; Jiang R; Hsu CH; Rashid A; Bhattacharrya AK; Ahnen DJ; Jacobs ET; Houlihan PS; Webb CR; Alberts DS; Hamilton SR
Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1443-50. PubMed ID: 16896030
[TBL] [Abstract][Full Text] [Related]
12. Position specificity of Ki-ras oncogene mutations during the progression of colorectal carcinoma.
Rochlitz CF; Heide I; de Kant E; Böhmer R; Peter FJ; Neuhaus P; Huhn D; Herrmann R
Oncology; 1993; 50(1):70-6. PubMed ID: 8421601
[TBL] [Abstract][Full Text] [Related]
13. [A joint study of mutation of the Ki-ras oncogene and overexpression of the Tp53 oncogene in colorectal cancer].
Laurent-Puig P; Delattre O; Olschwang S; Remvikos Y; Melot T; Salmon RJ; Frelat G; Thomas G
Gastroenterol Clin Biol; 1990; 14(4):347-51. PubMed ID: 2190855
[TBL] [Abstract][Full Text] [Related]
14. Occurrence of Ki-ras and p53 mutations in primary colorectal tumors.
Shaw P; Tardy S; Benito E; Obrador A; Costa J
Oncogene; 1991 Nov; 6(11):2121-8. PubMed ID: 1945416
[TBL] [Abstract][Full Text] [Related]
15. Ki-ras point mutation in different types of colorectal carcinomas in early stages.
Kojima M; Konishi F; Tsukamoto T; Yamashita K; Kanazawa K
Dis Colon Rectum; 1997 Feb; 40(2):161-7. PubMed ID: 9075750
[TBL] [Abstract][Full Text] [Related]
16. Recurrent KRAS codon 146 mutations in human colorectal cancer.
Edkins S; O'Meara S; Parker A; Stevens C; Reis M; Jones S; Greenman C; Davies H; Dalgliesh G; Forbes S; Hunter C; Smith R; Stephens P; Goldstraw P; Nicholson A; Chan TL; Velculescu VE; Yuen ST; Leung SY; Stratton MR; Futreal PA
Cancer Biol Ther; 2006 Aug; 5(8):928-32. PubMed ID: 16969076
[TBL] [Abstract][Full Text] [Related]
17. p53 and Ki-ras gene mutations in epithelial ovarian neoplasms.
Teneriello MG; Ebina M; Linnoila RI; Henry M; Nash JD; Park RC; Birrer MJ
Cancer Res; 1993 Jul; 53(13):3103-8. PubMed ID: 8319218
[TBL] [Abstract][Full Text] [Related]
18. Molecular staging of colorectal cancer: K-ras mutation analysis of lymph nodes upstages Dukes B patients.
Thebo JS; Senagore AJ; Reinhold DS; Stapleton SR
Dis Colon Rectum; 2000 Feb; 43(2):155-9; discussion 159-62. PubMed ID: 10696887
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Ki-ras and p53 gene mutations in laterally spreading tumors of the colorectum.
Noro A; Sugai T; Habano W; Nakamura S
Pathol Int; 2003 Dec; 53(12):828-36. PubMed ID: 14629748
[TBL] [Abstract][Full Text] [Related]
20. Detection of K-ras mutations in stools of patients with colorectal cancer by mutant-enriched PCR.
Nollau P; Moser C; Weinland G; Wagener C
Int J Cancer; 1996 May; 66(3):332-6. PubMed ID: 8621253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
